MedTrace Logo

Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma

NCT02255136 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-08-16

No results posted yet for this study

Summary

The purpose of this study is to test whether individualized homeopathic medicines can produce any significant effect beyond placebo in treatment of allergic rhinitis and/or induced bronchial asthma

Conditions

  • Rhinitis; Allergic, With Asthma

Interventions

OTHER

Individualized homeopathic medicines

5 ml dose of indicated individualized homeopathic medicine in centesimal or 50 millesimal potencies as appropriate; twice daily for 1 year

OTHER

Placebo

Placebo, in the form of a single drop of rectified spirit in 5 ml of distilled water

Sponsors & Collaborators

  • Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

    lead OTHER_GOV

Principal Investigators

  • Shubhamoy Ghosh, MD(Hom) · Lecturer of the Department of Pathology & Microbiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02255136 on ClinicalTrials.gov